Author`s Reply: ADMA is a useful marker, but many confounding factors should be considered!

We would like to thank the authors of the letter for their interest and criticism about our study entitled Could plasma asymmetric dimethylarginine level be a novel predictor beyond the classic predictors of stent restenosis? published in September issue of The Anatolian Journal of Cardiology 2014; 14: 491-7.